Document:

Exhibit
10.67

 

REGISTRATION
RIGHTS AGREEMENT
                 

THIS
REGISTRATION RIGHTS AGREEMENT, dated as of [●], 2022 (this “Agreement”), is by and among Interpace Biosciences,
Inc., a Delaware corporation (the “Company”), 3K Limited Partnership, a Delaware limited partnership (the “Standby
Purchaser”), Peter H. Kamin, a natural person in his individual capacity (“Mr. Kamin”), Peter H. Kamin Revocable
Trust dated February 2003 (the “2003 Trust”), Peter H. Kamin Childrens Trust dated March 1997 (the “1997
Trust”) and Peter H. Kamin Family Foundation (the “Foundation”). Each of the Standby Purchaser, Mr. Kamin,
the 2003 Trust, the 1997 Trust and the Foundation are referred to herein as an “Investor” and together the “Investors.”
                 

RECITALS
                 

WHEREAS,
on [●], 2022, the Company completed a rights offering (the “Rights Offering”) of non-transferable subscription
rights (the “Subscription  Rights”) to subscribe for and purchase shares of its common stock, par value
$0.01 per share (the “Common Stock  ”), to holders of Common Stock and certain holders of warrants (the “Eligible
Warrants”); 

 

 WHEREAS,
each holder of Common Stock or Eligible Warrants received one (1) Subscription Right to purchase one (1) share of Common Stock for every
share of Common Stock owned, including shares of Common Stock underlying the Eligible Warrants (the “Basic Subscription Privilege”),
and each holder of Subscription Rights who exercised in full his, her or its Basic Subscription Privilege was entitled to subscribe for
additional shares of Common Stock, to the extent available, at the Subscription Price; 
                 

WHEREAS,
on [●], 2022, pursuant to that certain Standby Purchase Agreement, dated as of [●], 2022 (the “Standby Purchase
Agreement”), by and among the Company and the Investors, the Investors exercised all of their Basic Subscription Rights
in full and the Standby Purchaser purchased from the Company, upon expiration of the Rights Offering, [●] additional shares of
Common Stock, offered pursuant to Subscription Rights but not otherwise subscribed for in the Rights Offering (the “Standby Offering”);
and
                 

WHEREAS,
in connection with the consummation of the transactions contemplated by the Standby Purchase Agreement, the parties desire to enter into
this Agreement in order to create certain registration rights for the Investors as set forth below.
                 

NOW,
THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valid consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows:
                 

Section
1. Certain Definitions.
                 

In
addition to the terms defined elsewhere in this Agreement, the following terms shall have the following meanings:
                 

“Affiliate”
of any Person means any other Person which directly, or indirectly through one or more intermediaries, controls, or is controlled by,
or is under common control with, such Person. The term “control” (including the terms “controlling,” “controlled”
and “under common control with”) as used with respect to any Person means the possession, direct or indirect, of the power
to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by
contract or otherwise.
                 

“Agreement”
means this Registration Rights Agreement, including all amendments, modifications and supplements and any exhibits or schedules to any
of the foregoing, and shall refer to this Registration Rights Agreement as the same may be in effect at the time such reference becomes
operative.
                 

    	 

    	 

    

 

“beneficially
own” means, with respect to any Person, securities of which such Person or any of such Person’s Affiliates, directly
or indirectly, has “beneficial ownership” as determined pursuant to Rule 13d-3 and Rule 13d-5 of the Exchange Act, including
securities beneficially owned by others with whom such Person or any of its Affiliates has agreed to act together for the purpose of
acquiring, holding, voting or disposing of such securities; provided that a Person shall not be deemed to “beneficially
own” (i) securities tendered pursuant to a tender or exchange offer made by such Person or any of such Person’s Affiliates
until such tendered securities are accepted for payment, purchase or exchange, (ii) any security as a result of an oral or written agreement,
arrangement or understanding to vote such security if such agreement, arrangement or understanding: (a) arises solely from a revocable
proxy given in response to a public proxy or consent solicitation made pursuant to, and in accordance with, the applicable provisions
of the Exchange Act, and (b) is not also then reportable by such Person on a Schedule 13D under the Exchange Act (or any comparable or
successor report). Without limiting the foregoing, a Person shall be deemed to be the beneficial owner of all Registrable Shares owned
of record by any majority-owned subsidiary of such Person.
                 

“Common
Stock” has the meaning set forth in the first Recital hereto.
                 

“Company”
has the meaning set forth in the Preamble.
                 

“Demand
Registration” has the meaning set forth in Section 2(a).
                 

“Demand
Registration Statement” has the meaning set forth in Section 2(a).
                 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.
                 

“Governmental
Entity” means any national, federal, state, municipal, local, territorial, foreign or other government or any department, commission,
board, bureau, agency, regulatory authority or instrumentality thereof, or any court, judicial, administrative or arbitral body or public
or private tribunal.
                 

“Holdback
Agreement” has the meaning set forth in Section 4.
                 

“Holdback
Period” has the meaning set forth in Section 4.
                 

“Minimum
Amount” means One Million Dollars ($1,000,000) of Registrable Shares.
                 

“Person”
means any individual, sole proprietorship, partnership, limited liability company, joint venture, trust, incorporated organization, association,
corporation, institution, public benefit corporation, Governmental Entity or any other entity.
                 

“Prospectus”
means the prospectus or prospectuses (whether preliminary or final) included in any Registration Statement and relating to Registrable
Shares, as amended or supplemented and including all material incorporated by reference into such prospectus or prospectuses.
                 

“Registrable
Shares” means (i) the shares of Common Stock acquired by the Standby Purchaser pursuant to the Standby Purchase Agreement,
(ii) the shares of Common Stock held by the Investors from time to time during the terms of this Agreement and (iii) any shares of capital
stock of the Company issued or issuable with respect to the Common Stock as a result of any stock split, stock dividend, recapitalization,
exchange or similar event or otherwise; provided, however, that such shares of Common Stock shall cease to be Registrable Shares
when such securities (a) have been sold pursuant to an effective registration statement or Rule 144 under the Securities Act, (b) have
been sold in a transaction where a subsequent public distribution of such securities would not require registration under the Securities
Act, (c) are eligible for sale pursuant to Rule 144 under the Securities Act without limitation thereunder on volume, manner of sale
or otherwise, or (d) are no longer outstanding. It is understood and agreed that, once such shares of Common Stock cease to be
a Registrable Share, such security shall cease to be a Registrable Share for all purposes of this Agreement and the Company’s obligations
regarding Registrable Shares hereunder shall cease to apply with respect to such security.
                 

    	2

    	 

    

 

“Registration
Expenses” has the meaning set forth in Section 6(a).
                 

“Registration
Statement” means any registration statement of the Company that covers any of the Registrable Shares pursuant to the provisions
of this Agreement, including the Prospectus, amendments and supplements to such Registration Statement, including post-effective amendments,
all exhibits, and all documents incorporated by reference in such Registration Statement.
                 

“Rights”
means non-transferable subscription rights to purchase Common Stock.
                 

“Rights
Offering” means the distribution of Rights by the Company, at no charge, to holders of record of its Common Stock.
                 

“SEC”
means the U.S. Securities and Exchange Commission or any successor agency.
                 

“Securities
Act” means the Securities Act of 1933, as amended.
                 

“Shares”
means any shares of Common Stock.
                 

“Standby
Offering” has the meaning set forth in the second Recital hereto.
                 

“Standby
Purchase Agreement” means the agreement specified in the second Recital hereto, as such agreement may be amended from time
to time.
                 

“Standby
Purchaser” means the entity named as such in the Preamble.
                 

“Suspension
Period” has the meaning set forth in Section 3.
                 

“Termination
Date” means the first date on which there are no Registrable Shares.
                 

Other
Terms: In addition to the above definitions, unless the context requires otherwise:
                 

(i)
any reference to any statute, regulation, rule or form as of any time shall mean such statute, regulation, rule or form as amended or
modified and shall also include any successor statute, regulation, rule or form from time to time;
                 

    	3

    	 

    

 

(ii)
“including” shall be construed as inclusive without limitation, in each case notwithstanding the absence of any express statement
to such effect, or the presence of such express statement in some contexts and not in others;
                 

(iii)
references to “Section” are references to Sections of this Agreement;
                 

(iv)
words such as “herein”, “hereof”, “hereinafter” and “hereby” when used in this Agreement
refer to this Agreement as a whole;
                 

(v)
references to “business day” mean any day except Saturday, Sunday and any other day on which commercial banks in The City
of New York are authorized or required by law to remain closed, provided that banks shall not be deemed to be authorized or obligated
to be closed due to a “shelter in place,” “non-essential employee” or similar closure of physical branch locations
at the direction of any governmental authority if such banks’ electronic funds transfer systems (including for wire transfers)
are open for use by customers on such day; and
                 

(vi)
references to “dollars” and “$” mean U.S. dollars.
                 

Section
2. Demand Registration.
                 

(a)
Right to Request Registration. Subject to the provisions hereof, until the Termination Date, one or more Investors may at any
time request registration for resale under the Securities Act of all or part of their Registrable Shares (a “Demand Registration”).
Subject to Section 2(d) and Section 4 and Section 6 below, the Company shall use reasonable best efforts (i) to
file a Registration Statement registering for resale such number of Registrable Shares as requested to be so registered pursuant to this
Section 2(a) (a “Demand Registration Statement”) within 45 calendar days after the Investor’s request
therefor, and (ii) if necessary, to promptly cause such Demand Registration Statement to be declared effective by the SEC as soon as
practical thereafter. If permitted under the Securities Act, such Registration Statement shall be one that is automatically effective
upon filing. The Demand Registration Statement shall allow the offer and sale of the Registrable Shares on a continuous basis pursuant
to Rule 415 under the Securities Act, unless the Company is not eligible to use a form which allows such offer and sale in which case
the Demand Registration Statement shall allow such offer and resale for so long a period as permitted by applicable Securities Law and
the rules thereunder.
                 

(b)
Number of Demand Registrations. Subject to the limitations of Section 2(a), Section 2(d) and Section 3(a),
the Investors shall be entitled to request up to three (3) Demand Registrations in the aggregate. A Registration Statement shall not
count as a permitted Demand Registration unless and until it has become effective.
                 

(c)
No Inclusion of Other Securities. The Company shall in no event include any securities other than Registrable Shares on any Registration
Statement filed in accordance with Section 2(a) without the prior written consent of the applicable Investors.
                 

(d)
Restrictions on Demand Registrations. The Investor shall not be entitled to request a Demand Registration if there is effective
a Demand Registration Statement that permits the offer and sale of the Registrable Shares on a continuous basis under Rule 415.
                 

    	4

    	 

    

 

(f)
Effective Period of Demand Registrations. The Company shall use reasonable best efforts to keep any Demand Registration Statement
effective for sale on a continuous basis under Rule 415, including by filing such post-effective amendments and supplements as are required
by the Securities Act, until the date on which all the Registrable Shares subject to such Demand Registration Statement have been sold.
If Rule 415 is unavailable to the Company, the Company shall use reasonable best efforts to keep such Demand Registration Statement effective
for a period equal to 120 days from such date, or such shorter period, when all of the Registrable Shares covered by such Demand Registration
have been sold by the applicable Investors. If the Company shall withdraw any Demand Registration pursuant to Section 4 before
such 120 days end and before all of the Registrable Shares covered by such Demand Registration have been sold pursuant thereto, such
Investors shall be entitled to a replacement Demand Registration which shall be subject to all of the provisions of this Agreement. A
Demand Registration shall not count against the limit on the number of such registrations set forth in Section 2(b) if (i) after
the applicable Registration Statement has become effective, such Registration Statement or the related offer, sale or distribution of
Registrable Shares thereunder becomes the subject of any stop order, injunction or other order or restriction imposed by the SEC or any
other governmental agency or court for any reason not primarily attributable to such Investors or their Affiliates (other than the Company
and its controlled Affiliates) and such interference is not thereafter eliminated so as to permit the completion of the contemplated
distribution of Registrable Shares, or (ii) in the case of an underwritten offering, the conditions specified in the related underwriting
agreement, if any, are not satisfied or waived for any reason not primarily attributable to the such Investors or their Affiliates (other
than the Company and its controlled Affiliates), and as a result of any such circumstances described in clause (i) or (ii), less than
75% of the Registrable Shares covered by the Registration Statement are sold by such Investors pursuant to such Registration Statement.
                 

Section
3. Suspension Periods.
                 

(a)
Suspension Periods. The Company may delay the filing or effectiveness of a Registration Statement in conjunction with a Demand
Registration, only if the Company’s board of directors reasonably determines (x) that proceeding with such an offering would require
the Company to disclose material information that would not otherwise be required to be disclosed at that time and that the disclosure
of such information at that time would not be in the Company’s best interests, or (y) that the registration or offering to be delayed
would, if not delayed, materially adversely affect the Company and its subsidiaries taken as a whole or materially interfere with, or
jeopardize the success of, any pending or proposed material transaction, including any debt or equity financing, any acquisition or disposition,
any recapitalization or reorganization or any other material transaction, whether due to commercial reasons, a desire to avoid premature
disclosure of information or any other reason. Any period during which the Company has delayed a filing, an effective date or an offering
pursuant to this Section 3 is herein called a “Suspension Period”; provided that such period may not exceed
75 consecutive days, and that the Company may not postpone or suspend its obligation under this Section 3(a) for more than 90
days in the aggregate during any 12-month period. If pursuant to this Section 3 the Company delays or withdraws a Demand Registration
requested by one or more Investors, such Investors shall be entitled to withdraw such request and, if it does so, such request shall
not count against the limitation on the number of such registrations set forth in Section 2; provided, however, such determination
shall not relieve the Company of its obligation to pay expenses in accordance with Section 6 hereof. The Company shall provide
prompt written notice to such Investors of the commencement and termination of any Suspension Period (and any withdrawal of a registration
statement pursuant to this Section 3), but shall not be obligated under this Agreement to disclose the reasons therefor. The Investor
shall keep the existence of each Suspension Period confidential.
                 

    	5

    	 

    

 

(b)
Other Lockups. Notwithstanding any other provision of this Agreement, the Company shall not be obligated to take any action hereunder
that would violate any lockup or similar restriction binding on the Company in connection with a prior or pending registration or underwritten
offering. The Company shall take all necessary action to obtain waivers or consent of the parties to any lockup agreements to the extent
required to prevent any action hereunder taken by the Company from violating any lockup or similar restriction binding on the Company
in connection with a prior or pending registration or underwritten offering.
                 

Section
4. Holdback Agreements. The restrictions in this Section 4 shall apply for as long as the Investors are beneficial owners
of any Registrable Shares. If the Company sells Shares or other securities convertible into or exchangeable for (or otherwise representing
a right to acquire) Shares in a primary underwritten offering pursuant to any registration statement under the Securities Act, and if
the managing underwriters for such offering advise the Company (in which case the Company promptly shall notify the Investors) that a
public sale or distribution of Shares outside such offering would materially adversely affect such offering, then, if requested by the
Company, the Investors shall agree, as contemplated in this Section 4, not to (and to cause their majority-controlled Affiliates
not to) sell, transfer, pledge, issue, grant or otherwise dispose of, directly or indirectly (including by means of any short sale),
or request the registration of, any Registrable Shares (or any securities of any Person that are convertible into or exchangeable for,
or otherwise represent a right to acquire, any Registrable Shares) for a period (each such period, a “Holdback Period”)
beginning on the 10th day before the pricing date for the underwritten offering and extending through the earlier of (i) the 90th day
after such pricing date (subject to customary automatic extension in the event of the release of earnings results of or material news
relating to the Company), and (ii) such earlier day (if any) as may be designated for this purpose by the managing underwriters for such
offering (each such agreement of the Investor, a “Holdback Agreement”). Each Holdback Agreement shall be in writing
in form and substance satisfactory to the Company and the managing underwriters. A Holdback Agreement shall not apply to (i) the exercise
of any warrants or options to purchase shares of the Company; provided that such restrictions shall apply with respect to the
securities issuable upon such exercise), or (ii) any Shares included in the underwritten offering giving rise to the application of this
Section 4.
                 

Section
5. Registration Procedures.
                 

(a)
Whenever one or more Investors request that any Registrable Shares be registered pursuant to this Agreement, the Company shall use reasonable
best efforts to effect, as soon as practical as provided herein, the registration and the sale of such Registrable Shares in accordance
with the intended methods of disposition thereof, and, pursuant thereto, the Company shall, as soon as practical as provided herein:
                 

    	6

    	 

    

 

(i)
subject to the other provisions of this Agreement, use reasonable best efforts to prepare and file with the SEC a Registration Statement
with respect to such Registrable Shares and cause such Registration Statement to become effective (unless it is automatically effective
upon filing);
                 

(ii)
use reasonable best efforts to prepare and file with the SEC such amendments and supplements to such Registration Statement and the Prospectus
used in connection therewith as may be necessary to comply with the applicable requirements of the Securities Act and to keep such Registration
Statement effective for the relevant period required hereunder, but no longer than is necessary to complete the distribution of the Shares
covered by such Registration Statement, and to comply with the applicable requirements of the Securities Act with respect to the disposition
of all the Shares covered by such Registration Statement during such period in accordance with the intended methods of disposition set
forth in such Registration Statement;
                 

(iii)
use reasonable best efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement, or the
lifting of any suspension of the qualification or exemption from qualification of any Registrable Shares for sale in any jurisdiction
in the United States;
                 

(iv)
use reasonable best efforts to register or qualify such Registrable Shares under such other securities laws or blue sky laws of such
U.S. jurisdictions (other than California) as such Investors reasonably request and continue such registration or qualification in effect
in such jurisdictions for as long as the applicable Registration Statement may be required to be kept effective under this Agreement
(provided that the Company will not be required to (x) qualify generally to do business in any jurisdiction where it would not otherwise
be required to qualify but for this subparagraph (iv), (y) subject itself to taxation in any such jurisdiction or (z) consent to general
service of process in any such jurisdiction);
                 

(v)
notify such Investors and each distributor of such Registrable Shares identified by such Investors, at any time when a Prospectus relating
thereto would be required under the Securities Act to be delivered by such distributor, of the occurrence of any event as a result of
which the Prospectus included in such Registration Statement contains an untrue statement of a material fact or omits a material fact
necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and, at the request
of the Investor, the Company shall use reasonable best efforts to prepare, as soon as reasonably practical, a supplement or amendment
to such Prospectus so that, as thereafter delivered to any prospective purchasers of such Registrable Shares, such Prospectus shall not
contain an untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading;
                 

(vi)
in the case of an underwritten offering in which such Investors participate pursuant to a Demand Registration, enter into an underwriting
agreement, containing customary provisions (including provisions for indemnification, lockups, opinions of counsel and comfort letters),
and take all such other customary and reasonable actions as the managing underwriters of such offering may request in order to facilitate
the disposition of such Registrable Shares (including, making members of senior management of the Company available at reasonable times
and places to participate in “road-shows” that the managing underwriter determines are necessary to effect the offering);
                 

    	7

    	 

    

 

(vii)
in the case of an underwritten offering in which such Investors participate pursuant to a Demand Registration, and to the extent not
prohibited by applicable law, (A) make reasonably available, for inspection by the managing underwriters of such offering and one attorney
and accountant acting for such managing underwriters, pertinent corporate documents and financial and other records of the Company and
its subsidiaries and controlled Affiliates, (B) cause the Company’s officers and employees to supply information reasonably requested
by such managing underwriters or attorney in connection with such offering, (C) make the Company’s independent accountants available
for any such managing underwriters’ due diligence and have them provide customary comfort letters to such underwriters in connection
therewith, and (D) cause the Company’s counsel to furnish customary legal opinions to such underwriters in connection therewith
including but not limited to a customary 10b-5 style opinion; provided, however, that such records and other information
shall be subject to such confidential treatment as is customary for underwriters’ due diligence reviews;
                 

(viii)
use reasonable best efforts to cause all such Registrable Shares to be listed on each primary securities exchange (if any) on which securities
of the same class issued by the Company are then listed;
                 

(ix)
provide a transfer agent and registrar for all such Registrable Shares not later than the effective date of such Registration Statement;
                 

(x)
notify such Investors:
                 

(1)
when the Registration Statement, any pre-effective amendment, the Prospectus or any Prospectus supplement or any post-effective amendment
to the Registration Statement has been filed and, with respect to the Registration Statement or any post-effective amendment, when the
same has become effective;
                 

(2)
of any request by the SEC for amendments or supplements to the Registration Statement or the Prospectus or for any additional information
regarding the Investor;
                 

(3)
of the notification to the Company by the SEC of its initiation of any proceeding with respect to the issuance by the SEC of any stop
order suspending the effectiveness of the Registration Statement; and
                 

(4)
of the receipt by the Company of any notification with respect to the suspension of the qualification of any Registrable Shares for sale
under the applicable securities laws or blue sky laws of any jurisdiction.
                 

For
the avoidance of doubt, the provisions of clauses (vi) and (vii), of this Section 5(a) shall apply only in respect of an underwritten
offering.
                 

(xi)
take all such other actions as may be reasonably requested by the Investor to cause the registration and sale of the Registrable Shares.
                 

    	8

    	 

    

 

(b)
No Registration Statement (including any amendments thereto) shall contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein, or necessary to make the statements therein not misleading, and no Prospectus (including
any supplements thereto) shall contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading, in each case, except for any untrue statement
or alleged untrue statement of a material fact or omission or alleged omission of a material fact made in reliance on and in conformity
with information furnished to the Company by or on behalf of the Investor or any underwriter or other distributor specifically for use
therein.
                 

(c)
At all times after the Company has filed a Registration Statement with the SEC pursuant to the requirements of the Securities Act and
until the Termination Date, the Company shall use reasonable best efforts to continuously maintain in effect the registration statement
of Common Stock under Section 12 of the Exchange Act and to use reasonable best efforts to file all reports required to be filed by it
under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder.
                 

(d)
The Company may require such Investors and each distributor of Registrable Shares as to which any registration is being effected to furnish
to the Company information regarding such Person and the distribution of such securities as the Company may from time to time reasonably
request in connection with such registration.
                 

(e)
Such Investors agree by having their Common Stock treated as Registrable Shares hereunder that, upon being advised by the Company of
the occurrence of an event pursuant to Section 5(a)(v), such Investors will immediately discontinue (and direct any other Persons
making offers and sales of Registrable Shares to immediately discontinue) offers and sales of Registrable Shares pursuant to any Registration
Statement (other than those pursuant to a plan that is in effect prior to such time and that complies with Rule 10b5-1 of the Exchange
Act) until it is advised by the Company that the use of the Prospectus may be resumed and is furnished with a supplemented or amended
Prospectus as contemplated by Section 5(a)(v), and, if so directed by the Company, such Investors will deliver to the Company
all copies, other than permanent file copies then in the such Investors’ possession, of the Prospectus covering such Registrable
Shares current at the time of receipt of such notice.
                 

(f)
The Company may prepare and deliver an issuer free-writing prospectus (as such term is defined in Rule 405 under the Securities Act)
in lieu of any supplement to a prospectus, and references herein to any “supplement” to a Prospectus shall include any such
issuer free-writing prospectus. No Investor nor any other seller of Registrable Shares may use a free-writing prospectus to offer or
sell any such Shares without the Company’s prior written consent, which consent shall not be unreasonably withheld, delayed or
conditioned.
                 

(g)
It is understood and agreed that any failure of the Company to file a Registration Statement or any amendment or supplement thereto or
to cause any such document to become or remain effective or usable within or for any particular period of time as provided in Section
2, Section 3 or Section 5 or otherwise in this Agreement, due to reasons that are not reasonably within its control,
or due to any refusal of the SEC to permit a Registration Statement or prospectus to become or remain effective or to be used because
of unresolved SEC comments thereon (or on any documents incorporated therein by reference) despite the Company’s good faith and
reasonable best efforts to resolve those comments, shall not be a breach of this Agreement. Notwithstanding any provision herein to the
contrary, the Company shall timely respond in writing to comments made by the SEC in respect of a Registration Statement as soon as practicable,
but in no event later than fifteen (15) days after the receipt of comments by or notice from the SEC that an amendment is required in
order for a Registration Statement to be declared effective.
                 

    	9

    	 

    

 

(h)
It is further understood and agreed that the Company shall not have any obligations under this Section 5 at any time on or after
the Termination Date, unless an underwritten offering in which an Investor participates has been priced but not completed prior to the
Termination Date, in which event the Company’s obligations under this Section 5 shall continue with respect to such offering
until it is so completed (but not more than 60 calendar days after the commencement of the offering).
                 

(i)
Notwithstanding anything to the contrary in this Agreement, the Company shall not be required to file a Registration Statement or include
Registrable Shares in a Registration Statement unless it has received from such Investors, at least two calendar days prior to the anticipated
filing date of the Registration Statement, requested information required to be provided by the Investor for inclusion therein.
                 

Section
6. Registration Expenses.
                 

(a)
All fees and expenses incident to the Company’s performance of or compliance with this Agreement, including all registration and
filing fees, fees and expenses of compliance with securities laws or blue sky laws, FINRA fees, fees with respect to filings required
to be made with the SEC, listing application fees, printing expenses, transfer agent’s and registrar’s fees, cost of printing
and distributing Prospectuses in preliminary and final form as well as any supplements thereto, messenger, telephone and delivery expenses,
the expense of any liability insurance, fees, disbursements and expenses of all other Persons retained by the Company in connection with
the consummation of the transactions contemplated by this Agreement, including, without limitation, the Company’s independent certified
public accountants (including the expenses of any comfort letters or costs associated with the delivery by independent certified public
accountants of a comfort letter or comfort letters, if requested by an underwriter) and legal counsel for the Company (all such expenses
being herein called “Registration Expenses”) (but not including any underwriting discounts or commissions attributable
to the sale of Registrable Shares), shall be borne by the Company. The Company shall also be responsible for all of its internal expenses
incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries
and expenses of its officers and employees performing legal or accounting duties), and the expense of any audit. In addition, the Company
shall pay all of the Investors’ reasonable and documented costs and expenses, including all fees and expenses of any counsel representing
such Investors, except that the Investors shall bear the cost of all underwriting discounts and commissions associated with any sale
of Registrable Shares.
                 

(b)
The obligation of the Company to bear the expenses described in Section 6(a) shall apply irrespective of whether a registration,
once properly demanded or requested becomes effective or is delayed, withdrawn or suspended; provided, however, that Registration
Expenses for any Registration Statement withdrawn solely at the request of the Investors (unless withdrawn following commencement of
a Suspension Period pursuant to Section 3) shall be borne by the applicable Investors.
                 

    	10

    	 

    

 

Section
7. Indemnification.
                 

(a)
The Company shall indemnify, to the fullest extent permitted by law, each Investor, the officers, directors, partners, trustees, beneficiaries,
agents, and employees of each of them, and each Person who controls such Investor (within the meaning of the Securities Act) and the
officers, directors, partners, trustees, beneficiaries, agents and employees of each such controlling Person, against any and all losses,
claims, damages, liabilities, judgments, costs (including reasonable costs of investigation) and expenses (including reasonable attorneys’
fees) arising out of or based upon any untrue or alleged untrue statement of a material fact contained or incorporated by reference in
any Registration Statement or Prospectus or any amendment thereof or supplement thereto or arising out of or based upon any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, except
to the extent, but only to the extent that such untrue statements or omissions are based solely upon information regarding such Investor
furnished to the Company by such Investor expressly for use therein, which information was reasonably relied on by the Company for use
therein or to the extent that such information relates to such Investor or such Investor’s proposed method of distribution of Registrable
Securities. In connection with an underwritten offering in which such Investor participates conducted pursuant to a registration effected
hereunder, the Company shall indemnify each participating underwriter and each Person who controls such underwriter (within the meaning
of the Securities Act) to the same extent as provided above with respect to the indemnification of such Investor.
                 

(b)
In connection with any Registration Statement in which an Investor is participating, such Investor shall furnish to the Company in writing
such information as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus, or amendment
or supplement thereto, and shall indemnify, severally and not jointly, to the fullest extent permitted by law, the Company, its officers
and directors and each Person who controls the Company (within the meaning of the Securities Act) against all losses, claims, damages,
liabilities, judgments, costs (including reasonable costs of investigation) and expenses (including reasonable attorneys’ fees)
arising out of or based upon any untrue or alleged untrue statement of material fact contained in the Registration Statement or Prospectus,
or any amendment or supplement thereto, or arising out of or based upon any omission or alleged omission of a material fact required
to be stated therein or necessary to make the statements therein not misleading, to the extent, but only to the extent, that such untrue
statement or omission is contained in or omitted from any information furnished by such Investor to the Company specifically for inclusion
in the Registration Statement or such Prospectus and that such information was reasonably relied upon by the Company for use in the Registration
Statement, such Prospectus or such form of prospectus or to the extent that such information relates to such Investor or such Investor’s
proposed method of distribution of Registrable Securities. Notwithstanding anything to the contrary contained herein, an Investor shall
be liable under this Section 7(b) for only that amount as does not exceed the net proceeds to such Investor as a result of the
sale of Registrable Shares pursuant to such Registration Statement.
                 

    	11

    	 

    

 

(c)
Any Person entitled to indemnification hereunder shall (i) give prompt written notice to the indemnifying Person of any claim with respect
to which it seeks indemnification, and (ii) permit such indemnifying Person to assume the defense of such claim with counsel reasonably
satisfactory to the indemnified Person. Failure so to notify the indemnifying Person shall not relieve it from any liability that it
may have to an indemnified Person except to the extent that the indemnifying Person is materially and adversely prejudiced thereby. The
indemnifying Person shall not be subject to any liability for any settlement made by the indemnified Person without its consent (but
such consent will not be unreasonably withheld). An indemnifying Person who is entitled to, and elects to, assume the defense of a claim
shall not be obligated to pay the fees and expenses of more than one counsel (in addition to one local counsel) for all Persons indemnified
(hereunder or otherwise) by such indemnifying Person with respect to such claim (and all other claims arising out of the same circumstances),
unless in the reasonable judgment of any indemnified Person there may be one or more legal or equitable defenses available to such indemnified
Person which are in addition to or may conflict with those available to another indemnified Person with respect to such claim, in which
case such maximum number of counsel for all indemnified Persons shall be two rather than one). If an indemnifying Person is entitled
to, and elects to, assume the defense of a claim, the indemnified Person shall continue to be entitled to participate in the defense
thereof, with counsel of its own choice, but, except as set forth above, the indemnifying Person shall not be obligated to reimburse
the indemnified Person for the costs thereof. The indemnifying Person shall not consent to the entry of any judgment or enter into or
agree to any settlement relating to a claim or action for which any indemnified Person would be entitled to indemnification by any indemnified
Person hereunder unless such judgment or settlement imposes no ongoing obligations on any such indemnified Person and includes as an
unconditional term the giving, by all relevant claimants and plaintiffs to such indemnified Person, a release, satisfactory in form and
substance to such indemnified Person, from all liabilities in respect of such claim or action for which such indemnified Person would
be entitled to such indemnification. The indemnifying Person shall not be liable hereunder for any amount paid or payable or incurred
pursuant to or in connection with any judgment entered or settlement effected with the consent of an indemnified Person unless the indemnifying
Person has also consented to such judgment or settlement.
                 

(d)
The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or
on behalf of the indemnified Person or any officer, director or controlling Person of such indemnified Person and shall survive the transfer
of securities and the Termination Date but only with respect to offers and sales of Registrable Shares made before the Termination Date
or during the period following the Termination Date referred to in Section 5(h).
                 

(e)
If the indemnification provided for in or pursuant to this Section 7 is due in accordance with the terms hereof, but is held by
a court to be unavailable or unenforceable in respect of any losses, claims, damages, liabilities or expenses referred to herein, then
each applicable indemnifying Person, in lieu of indemnifying such indemnified Person, shall contribute to the amount paid or payable
by such indemnified Person as a result of such losses, claims, damages, liabilities or expenses in such proportion as is appropriate
to reflect the relative fault of the indemnifying Person on the one hand and of the indemnified Person on the other in connection with
the statements or omissions which result in such losses, claims, damages, liabilities or expenses as well as any other relevant equitable
considerations. The relative fault of the indemnifying Person on the one hand and of the indemnified Person on the other shall be determined
by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission
to state a material fact relates to information supplied by the indemnifying Person or by the indemnified Person, and by such Person’s
relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. In no event shall
the liability of the indemnifying Person be greater in amount than the amount for which such indemnifying Person would have been obligated
to pay by way of indemnification if the indemnification provided for under Section 7(a) or Section 7(b) hereof had been
available under the circumstances.
                 

    	12

    	 

    

 

Section
8. Rule 144.
                 

As
long as any Investor owns Registrable Shares, the Company covenants to timely file all reports required to be filed by the Company after
the date hereof pursuant to Section 13(a) or 15(d) of the Exchange Act. As long as any Investor owns Registrable Shares, if the Company
is not required to file reports pursuant to Section 13(a) or 15(d) of the Exchange Act, it will prepare and furnish to the Investor and
make publicly available in accordance with Rule 144(c) promulgated under the Securities Act annual and quarterly financial statements,
together with a discussion and analysis of such financial statements in form and substance substantially similar to those that would
otherwise be required to be included in reports required by Section 13(a) or 15(d) of the Exchange Act, as well as any other information
required thereby, in the time period that such filings would have been required to have been made under the Exchange Act. The Company
further covenants that it will take such further action as any Investor may reasonably request, all to the extent required from time
to time to enable such Person to sell Registrable Shares without registration under the Securities Act within the limitation of the exemptions
provided by Rule 144 promulgated under the Securities Act.
                 

Section
9. Miscellaneous.
                 

(a)
Notices. Any notice, request, instruction or other document to be given hereunder by any party to the other will be in writing
and will be deemed to have been duly given (a) on the date of delivery if delivered personally, by fax or email transmission, upon confirmation
of receipt, or (b) on the second business day following the date of dispatch if delivered by a recognized next day courier service. All
notices hereunder shall be delivered as set forth below, or pursuant to such other instructions as may be designated in writing by the
party to receive such notice.
                 

If
to the Company:
                 

Interpace
Biosciences, Inc.

Morris Corporate Center 1, Building C

300
Interpace Parkway

Parsippany,
New Jersey 07054

Attention:
Thomas W. Burnell, Chief Executive Officer and Director

Email:
tburnell@interpace.com
                 

    	13

    	 

    

 

With
a copy (which shall not constitute notice) to:
                 

Troutman
Pepper Hamilton Sanders LLP

875
Third Avenue

New
York, NY 10022

Attention:
Merrill M. Kraines

Email: Merrill.Kraines@Troutman.com
                 

If
to the Investors:
                 

3K
Limited Partnership

c/o Peter H. Kamin

2720 Donald Ross Road, #311

Palm Beach Gardens, FL 33410

Attention:
Peter H. Kamin

Email: pkamin@3klp.com
                 

With
a copy (which shall not constitute notice) to:
                 

Sullivan
& Worcester LLP

1633
Broadway

New
York, N.Y. 10019

Attention:
David E. Danovitch

Email:
ddanovitch@sullivanlaw.com
                 

However,
the foregoing shall not limit the right of a party to effect service of process on any other party by any other legally available method.
                 

(b)
No Waivers. No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof
nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power
or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law.
                 

(c)
Assignment. Neither this Agreement nor any right, remedy, obligation nor liability arising hereunder or by reason hereof shall
be assignable by any party hereto without the prior written consent of the other party, and any attempt to assign any right, remedy,
obligation or liability hereunder without such consent shall be void, except (1) an assignment, in the case of a merger or consolidation
where such party is not the surviving entity, or a sale of substantially all of its assets, to the entity which is the survivor of such
merger or consolidation or the purchaser in such sale or (2) that an Investor shall have the right to assign this Agreement, and all
of its rights and obligations hereunder, to any Affiliate to which it transfers its Registrable Shares.
                 

(d)
No Third-Party Beneficiaries. Except as provided in Section 7 with respect to the indemnified Persons, nothing contained
in this Agreement, expressed or implied, is intended to confer upon any person or entity other than the Company and the Investors, any
benefits, rights, or remedies.
                 

    	14

    	 

    

 

(e)
Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without
giving effect to any choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would
cause the application of the Laws of any jurisdiction other than the State of Delaware.
                 

(f)
Jurisdiction. The parties hereby irrevocably and unconditionally consent to the exclusive jurisdiction of the Court of Chancery
of the State of Delaware, or to the extent such court does not have subject matter jurisdiction, the Superior Court of the State of Delaware
or the United States District Court of the State of Delaware, for any action, suit or proceeding arising out of or relating to this Agreement,
and agree not to commence any action, suit or proceeding related thereto except in such courts. The parties further hereby irrevocably
and unconditionally waive any objection to the laying of venue of any action, suit or proceeding arising out of or relating to this agreement
in the Court of Chancery of the State of Delaware, or to the extent such court does not have subject matter jurisdiction, the Superior
Court of the State of Delaware or the United States District Court of the State of Delaware. The parties hereby consent to and grant
any such court jurisdiction over the person of such parties and over the subject matter of any such dispute and agree that mailing of
process or other papers in connection with any such action or proceeding in the manner provided in Section 9(a), or in such other
manner as may be permitted by applicable Law, shall be valid and sufficient service thereof.
                 

(g)
EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED
TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
                 

(h)
Counterparts and Electronic Transmission. This Agreement may be executed in any number of separate counterparts, including via
electronic means, each such counterpart being deemed to be an original instrument, and all such counterparts will together constitute
the same agreement. Executed signature pages to this Agreement may be delivered by fax or other electronic transmission (including “.html,”
“.pdf”, “.tif” or similar commonly used electronic format) and will be deemed as sufficient as if actual signature
pages had been delivered.
                 

(i)
Entire Agreement. This Agreement contains the entire agreement between the parties hereto with respect to the subject matter hereof
and supersedes and replaces all other prior agreements, written or oral, among the parties hereto with respect to the subject matter
hereof.
                 

(j)
Captions. The headings and other captions in this Agreement are for convenience and reference only and shall not be used in interpreting,
construing or enforcing any provision of this Agreement.
                 

(k)
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction or
other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement
shall remain in full force and effect and shall in no way be affected, impaired or invalidated so long as the economic or legal substance
of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such a determination, the
parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible
in an acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent
possible.
                 

(m)
Amendment. No amendment of any provision of this Agreement will be effective unless made in writing and signed by an officer of
a duly authorized representative of each party.
                 

(n)
Further Assurances. Each party hereto shall do and perform or cause to be done and performed all such further acts and things
and shall execute and deliver all such other agreements, certificates, instruments and documents as any other party hereto reasonably
may request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.
                 

[Signature
Page Follows]
                 

    	15

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of as of the date first written above.
                 

	 	COMPANY:
	 	 	 
	 	INTERPACE
  BIOSCIENCES, INC.
	 	 	 
	 	By:	                 
	 	Name:	 
	 	Title:	 

                 

	INVESTORS:	 
	 	 	 
	3K
  LIMITED PARTNERSHIP	 
	 	 	 
	By:	                  	 
	Name:	 	 
	Title:	 	 

 

	PETER
    H. KAMIN	 
	 	 
	 	 
	 	 	 
	PETER
    H. KAMIN REVOCABLE TRUST DATED FEBRUARY 2003
	 	 	 
	By:	             	 
	Name:	 	 
	Title:	 	 

 

	PETER
    H. KAMIN CHILDRENS TRUST DATED MARCH 1997
	 	 	 
	By:	           	 
	Name:	 	 
	Title:	 	 

                 

	PETER
    H. KAMIN FAMILY FOUNDATION
	 	 	 
	By:	               	 
	Name:	 	 
	Title:	 	 

                 

[Signature
Page to Registration Rights Agreement]

 

    	 

    	 

    

 

SCHEDULE
I
                 

COMMON
STOCK OWNED BY INVESTORS
                 

	Name
    of Investor	 	Shares
    of Common Stock	 
	Peter
    H. Kamin	 	 	                     	 
	Peter
    H. Kamin Revocable Trust dated February 2003	 	 		 
	Peter
    H. Kamin Childrens Trust dated March 1997	 	 		 
	Peter
    H. Kamin Family Foundation	 	 		 
	3K
    Limited Partnership	 	 		 
	TotalExhibit
10.68

 

INVESTOR
RIGHTS AGREEMENT
              

This
Investor Rights Agreement (this “Agreement”) dated as of [●], 2022, by and among Interpace Biosciences, Inc.,
a Delaware corporation (the “Company”), 3K Limited Partnership, a Delaware limited partnership (the “Standby
Purchaser”), Peter H. Kamin, a natural person in his individual capacity (“Mr. Kamin”), Peter H. Kamin Revocable
Trust dated February 2003 (the “2003 Trust”), Peter H. Kamin Childrens Trust dated March 1997 (the “1997
Trust”) and Peter H. Kamin Family Foundation (the “Foundation”). Each of the Standby Purchaser, Mr. Kamin,
the 2003 Trust, the 1997 Trust and the Foundation are referred to herein as an “Investor” and together the “Investors”.
              

RECITALS
              

WHEREAS,
on [●], 2022, the Company completed a rights offering (the “Rights Offering”) of non-transferable subscription
rights (the “Subscription  Rights”) to subscribe for and purchase shares of its common stock, par value
$0.01 per share (the “Common Stock”), to holders of Common Stock and certain holders of warrants (the “Eligible
Warrants”) ;
              

 WHEREAS,
each holder of Common Stock or Eligible Warrants received one (1) Subscription Right to purchase one (1) share of Common Stock for every
share of Common Stock owned, including shares of Common Stock underlying the Eligible Warrants (the “Basic Subscription Privilege”),
and each holder of Subscription Rights who exercised in full his, her or its Basic Subscription Privilege was entitled to subscribe for
additional shares of Common Stock, to the extent available, at the Subscription Price; 

 

WHEREAS,
on [●], 2022, pursuant to that certain Standby Purchase Agreement, dated as of [●], 2022 (the “Standby
Purchase Agreement”), by and among the Company and the Investors, the Investors exercised all of their Basic
Subscription Rights in full and the Standby Purchaser purchased from the Company, upon expiration of the Rights Offering, such
[●] additional shares of Common Stock offered pursuant to Subscription Rights  but not otherwise subscribed for
in the Rights Offering (the “Standby Offering”); and
              

WHEREAS,
in connection with the consummation of the transactions contemplated by the Standby Purchase Agreement, the parties desire to enter into
this Agreement in order to grant certain rights to the Investors relating to the governance of the Company as set forth below.
              

NOW,
THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valid consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows:
              

Section
1. Definitions.
              

“Affiliate”
means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled
by, or is under common control with, such first Person.
              

“Agreement”
has the meaning specified in the Preamble.
              

“Board”
means the board of directors of the Company.
              

“Business
Day” means any day except Saturday, Sunday and any other day on which commercial banks in The City of New York are authorized
or required by law to remain closed, provided that banks shall not be deemed to be authorized or obligated to be closed due to a “shelter
in place,” “non-essential employee” or similar closure of physical branch locations at the direction of any governmental
authority if such banks’ electronic funds transfer systems (including for wire transfers) are open for use by customers on such
day.
              

    	1

     

    

 

“Bylaws”
means the Company’s Bylaws, as in effect on the date hereof, as the same may be amended from time to time.
              

“Certificate
of Incorporation” means the Company’s Certificate of Incorporation, as in effect on the date hereof, as the same may
be amended from time to time.
              

“Common
Stock” has the meaning specified in the Recitals.
              

“Company”
has the meaning specified in the Preamble.
              

“control”
(including the terms “controlling,” “controlled by” and “under common control with”)
means, unless otherwise noted, the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of a Person, whether through the ownership of voting shares, by contract, or otherwise.
              

“Director”
means a member of the Board until such individual’s death, disability, disqualification, resignation, or removal.
              

“Investor
Designated Director” means an individual elected to the Board that has been nominated by the Investors pursuant to this Agreement.
              

“Investors”
shall have the meaning set forth in the Preamble.
              

“Governmental
Entity” means any federal, state, provincial, local or foreign governmental, administrative or regulatory (including any stock
exchange) authority, agency, court, instrumentality, binding arbitration body, commission or other entity or self-regulatory organization.
              

“Nominee”
has the meaning specified in Section 2(a)(i).
              

“Person”
means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint
venture, an unincorporated organization and a Governmental Entity or any department, agency or political subdivision thereof.
              

“Rule
144” means Rule 144 promulgated under the Securities Act and any successor provision.
              

“SEC”
means the U.S. Securities and Exchange Commission.
              

“Securities
Act” means the Securities Act of 1933, as amended from time to time.
              

“Standby
Offering” has the meaning specified in the Recitals.
              

“Standby
Offering Closing Date” has the meaning specified in Section 2.
              

“Standby
Purchase Agreement” has the meaning specified in the Recitals.
              

“Standby
Purchaser” has the meaning specified in the Preamble.
              

    	2

     

    

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing), or, if the Common Stock is not listed on any of the foregoing markets or
exchanges, Trading Market shall refer to the over-the-counter market on which the Common Stock is quoted.
              

“Transfer”
means any sale, transfer, assignment or other disposition of (whether with or without consideration and whether voluntary or involuntary
or by operation of law) of Common Stock.
              

Section
2. Board of Directors.
              

(a)
Subject to the terms and conditions of this Agreement, from and after the date hereof (the “Standby Offering Closing Date”),
for so long as the Investors (together with their Affiliates) then hold shares of Common Stock representing at least 5.0% of the Company’s
fully-diluted capitalization (assuming the conversion of all outstanding convertible securities):
              

(i)
The Investors shall have the right, but not the obligation, to designate one person, subject to approval by the Nominating and Corporate
Governance Committee of the Board (the “Nominating Committee”), to be appointed to the Board by the other Board members
if prior to a meeting of stockholders or nominated, as the case may be, for election to the Board (including any successor, each, a “Nominee”)
by giving written notice to the Company following the date hereof and following such Nominee’s initial appointment on or before
the time such information is reasonably requested by the Board or the Nominating Committee for inclusion in a proxy statement for a meeting
of stockholders.
              

(ii)
The Company agrees to use all reasonable efforts to ensure that the rights granted under this Agreement are effective and that the parties
to this Agreement enjoy the benefits of such rights. Such actions include, without limitation, the use of the Company’s reasonable
efforts to assist in the nomination and election of the Investor Designated Director as provided herein. The Company will, as promptly
as practicable, use its best efforts to take all necessary and desirable actions (including, without limitation, calling special meetings
of the Board and the stockholders and recommending, supporting and soliciting proxies) so that there is an Investor Designated Director
serving on the Board at all times.
              

(iii)
The Company shall, to the fullest extent permitted by applicable law, use its best efforts to take all actions necessary to ensure that:
(i) there is at least one Board vacancy on the Standby Offering Closing Date and such vacancy remains open until the Investor Designated
Director is duly appointed; (ii) promptly after the initial Nominee has been submitted to the Nominating Committee, the Board appoints
such Nominee as a Director; (iii) once appointed, the Nominee is thereafter included in the Board’s slate of nominees to the stockholders
of the Company for each election of Directors; and (ii) such Nominee is included in the proxy statement prepared by management of the
Company in connection with soliciting proxies for every meeting of the stockholders of the Company called with respect to the election
of members of the Board, and at every adjournment or postponement thereof, and on every action or approval by written consent of the
stockholders of the Company or the Board with respect to the election of members of the Board. The Company shall not, by any voluntary
action, avoid or seek to avoid the observance or performance of any of the terms to be performed under this Agreement by the Company,
but shall at all times in good faith assist in the carrying out of all of the provisions of this Agreement and in the taking of all such
actions as may be necessary, appropriate, or reasonably requested by the Investors in order to protect the rights of the parties under
this Agreement against impairment.
              

    	3

     

    

 

(iv)
If a vacancy occurs because of the death, disability, disqualification, resignation, or removal of an Investor Designated Director or
for any other reason, the Investors shall be entitled to designate such person’s successor, and the Company will, as promptly as
practicable following such designation, use its best efforts to take all necessary and desirable actions, to the fullest extent permitted
by law, within its control such that such vacancy shall be filled with such successor Nominee.
              

(v)
If a Nominee is not elected because of such Nominee’s death, disability, disqualification, withdrawal as a nominee or for any other
reason, the Investors shall be entitled to designate promptly another Nominee and the Company will take all necessary and desirable actions
within its control such that the director position for which such Nominee was nominated shall not be filled pending such designation
or the size of the Board shall be increased by one and such vacancy shall be filled with such successor Nominee as promptly as practicable
following such designation.
              

(vi)
As promptly as reasonably practicable following the of the appointment or election of any Investor Designated Director, the Company shall
enter into an indemnification agreement with such Investor Designated Director, in the form entered into with the other members of the
Board.
              

(vii)
The Company shall purchase and at all times maintain directors’ and officers’ liability insurance in an amount determined
by the Board to be reasonable and customary.
              

(viii)
For so long as an Investor Designated Director serves as a Director of the Company, the Company shall not amend, alter or repeal any
right to indemnification or exculpation covering or benefiting any Director nominated pursuant to this Agreement as and to the extent
consistent with applicable law, whether such right is contained in the Certificate of Incorporation, Bylaws or another document (except
to the extent such amendment or alteration permits the Company to provide broader indemnification or exculpation rights on a retroactive
basis than permitted prior thereto).
              

(ix)
Each Nominee may, but does not need to qualify as “independent” pursuant to listing standards of any applicable Trading Market
or meet the additional qualifications for members of the audit committee or compensation committee pursuant to the rules and regulations
of the Securities and Exchange Commission.
              

    	4

     

    

 

(x)
Any Nominee will be subject to the Company’s customary due diligence process, including its review of a completed questionnaire
and a background check. Based on the foregoing, the Company may object to any Nominee provided (a) it does so in good faith, and (b)
such objection is based upon any of the following: (i) such Nominee was convicted in a criminal proceeding or is a named subject of a
pending criminal proceeding (excluding traffic violations and other minor offenses), (ii) such Nominee was the subject of any order,
judgment, or decree not subsequently reversed, suspended or vacated of any court of competent jurisdiction, permanently or temporarily
enjoining such proposed director from, or otherwise limiting, the following activities: (A) engaging in any type of business practice,
or (B) engaging in any activity in connection with the purchase or sale of any security or in connection with any violation of federal
or state securities laws, (iii) such Nominee was the subject of any order, judgment or decree, not subsequently reversed, suspended or
vacated, of any federal or state authority barring, suspending or otherwise limiting for more than 60 days the right of such person to
engage in any activity described in clause (ii)(B), or to be associated with persons engaged in such activity, (iv) such proposed director
was found by a court of competent jurisdiction in a civil action or by the SEC to have violated any federal or state securities law,
and the judgment in such civil action or finding by the SEC has not been subsequently reversed, suspended or vacated, or (v) such proposed
director was the subject of, or a party to any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently
reversed, suspended or vacated, relating to a violation of any federal or state securities laws or regulations. In the event the Board
reasonably finds the Nominee to be unsuitable based upon one or more of the foregoing clauses (i) through (v) and reasonably objects
to the identified director, the Investors shall be entitled to propose a different nominee to the Board within 30 calendar days of the
Company’s notice to the Investors of its objection to the Nominee and such replacement Nominee shall be subject to the review process
outlined above.
              

(xii)
For the avoidance of doubt, if the aggregate holdings of the Investors fall below the percentages set forth in clause (a)(i) immediately
above, the Investor Designated Director shall not be required to resign and may be renominated at the discretion of the Board.
              

Section
4.Notices. Any notice, request, instruction or other document to be given hereunder by any party to the other will be in writing
and will be deemed to have been duly given (a) on the date of delivery if delivered personally, by fax or email transmission, upon confirmation
of receipt, or (b) on the second Business Day following the date of dispatch if delivered by a recognized next day courier service. All
notices hereunder shall be delivered as set forth below, or pursuant to such other instructions as may be designated in writing by the
party to receive such notice.
              

If
to the Company:
              

Interpace
Biosciences, Inc.

Morris Corporate Center 1, Building C

300
Interpace Parkway

Parsippany,
New Jersey 07054

Attention:
Thomas W. Burnell, Chief Executive Officer and Director

Email:
tburnell@interpace.com
              

    	5

     

    

 

With
a copy (which shall not constitute notice) to:
              

Troutman
Pepper Hamilton Sanders LLP

875
Third Avenue

New
York, NY 10022

Attention:
Merrill M. Kraines

Email: Merrill.Kraines@Troutman.com
              

If
to the Investors:
              

3K
Limited Partnership

c/o Peter H. Kamin

2720 Donald Ross Road, #311

Palm Beach Gardens, FL 33410

Attention:
Peter H. Kamin

Email: pkamin@3klp.com
              

With
a copy (which shall not constitute notice) to:
              

Sullivan
& Worcester LLP

1633
Broadway

New
York, N.Y. 10019

Attention: David Danovitch

Email:
ddanovitch@sullivanlaw.com
              

However,
the foregoing shall not limit the right of a party to effect service of process on any other party by any other legally available method.
              

Section
5. Further Assurances. Each party hereto shall do and perform or cause to be done and performed all further acts and shall execute
and deliver all other agreements, certificates, instruments and documents as the other party hereto reasonably may request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.
              

Section
6. Amendments and Waivers. Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver
is in writing and is duly executed and delivered: (x) by the Company; and (y) by the Investors. No failure or delay by any party in exercising
any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any
other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall
be cumulative and not exclusive of any rights or remedies provided by Law.
              

Section
7. Successors and Assigns. This Agreement shall not be otherwise assignable or otherwise transferable (by operation of law or
otherwise) by any party hereto without the prior written consent of the other party hereto, except that an Investor shall have the right
to assign this Agreement, and all of its rights and obligations hereunder, to any Affiliate to which it transfers its shares of Common
Stock. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors
and permitted assigns.
              

    	6

     

    

 

Section
8. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware. The
parties hereby irrevocably submit to the exclusive jurisdiction of the Court of Chancery of the State of Delaware, or to the extent such
court does not have subject matter jurisdiction, the Superior Court of the State of Delaware or the United States District Court of the
State of Delaware, and hereby waive, and agree not to assert, as a defense in any action, suit or proceeding for the interpretation or
enforcement hereof, that it is not subject thereto or that such action, suit or proceeding may not be brought or is not maintainable
in said courts or that the venue thereof may not be appropriate or that this Agreement may not be enforced in or by said courts, and
the parties hereto irrevocably agree that all claims with respect to such action or proceeding shall be heard and determined in the Court
of Chancery of the State of Delaware, or to the extent such court does not have subject matter jurisdiction, the Superior Court of the
State of Delaware or the United States District Court of the State of Delaware. The parties hereby consent to and grant any such court
jurisdiction over the person of such parties and over the subject matter of any such dispute and agree that mailing of process or other
papers in connection with any such action or proceeding in the manner provided in Section 4, or in such other manner as may be
permitted by applicable Law, shall be valid and sufficient service thereof.
              

Section
9. Waiver of Jury Trial. Each party acknowledges and agrees that any controversy that may arise under this agreement is likely
to involve complicated and difficult issues, and therefore each such party hereby irrevocably and unconditionally waives any right such
party may have to a trial by jury in respect of any litigation directly or indirectly arising out of or relating to this agreement or
the transactions contemplated by this agreement.
              

Section
10. Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter of
this Agreement and supersedes all prior agreements and understandings, both oral and written, between the parties and/or their Affiliates
with respect to the subject matter of this Agreement.
              

Section
11. Effect of Headings and Table of Contents. The Article and Section headings herein and the Table of Contents are for convenience
only and shall not affect the construction hereof.
              

Section
12. Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable Law, such provision
shall be deemed to be excluded from this Agreement and the balance of this Agreement shall be interpreted as if such provision were so
excluded and shall be enforced in accordance with its terms to the maximum extent permitted by Law.
              

Section
13. Counterparts; No Third Party Beneficiaries. This Agreement may be signed in any number of counterparts (including by facsimile
or other electronic transmission), each of which shall be an original, with the same effect as if the signatures were upon the same instrument.
No provision of this Agreement shall confer upon any Person other than the parties hereto any rights or remedies hereunder.
              

Section
14. Specific Performance. The parties hereto agree that irreparable damage would occur in the event that any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that
the parties shall be entitled to an injunction or injunctions to prevent breaches of the provisions of this Agreement and to enforce
specifically the terms and provisions hereof in the Court of Chancery of the State of Delaware or, to the extent such courts does not
have subject matter jurisdiction, the United States District Court for the District of Delaware, and each party hereto agrees to waive
in any action for such enforcement the defense that a remedy at law would be adequate.
              

Section
15. Termination. The parties hereto may terminate this Agreement (i) if either party materially breaches its obligations under
this Agreement and such breach is not cured within five (5) Business Days following written notice to the breaching party or (ii) upon
the parties’ mutual written consent. Notwithstanding anything to the contrary contained herein, if the Investors (together with
their Affiliates) do not in the aggregate then hold shares of Common Stock representing at least 5.0% of the Company’s fully-diluted
capitalization (assuming the conversion of all outstanding convertible securities), then this Agreement shall expire and terminate automatically.
              

[Signature
page follows]
              

    	7

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement on the day and year first above written.
              

	 	COMPANY:
	 	 	 
	 	INTERPACE
  BIOSCIENCES, INC.
	 	 	 
	 	By:	                 
	 	Name:	 
	 	Title:	 

 

	INVESTORS:	 
	 	 	 
	3K
  LIMITED PARTNERSHIP	 
	 	 	 
	By:	                  	 
	Name:	 	 
	Title:	 	 

 

	PETER
    H. KAMIN	 
	 	 
	 	 
	 	 	 
	PETER
    H. KAMIN REVOCABLE TRUST DATED FEBRUARY 2003
	 	 	 
	By:	             	 
	Name:	 	 
	Title:	 	 

              

	PETER
    H. KAMIN CHILDRENS TRUST DATED MARCH 1997
	 	 	 
	By:	           	 
	Name:	 	 
	Title:	 	 

 

	PETER
    H. KAMIN FAMILY FOUNDATION
	 	 	 
	By:	               	 
	Name:	 	 
	Title:	 	 

              

[Signature
Page to Investor Rights Agreement]

 

    	 

     

    

 

Schedule
I

Investors
              

	Name
    of Investor	 	Shares
    of Common Stock	 
	Peter
    H. Kamin	 	 	                 	 
	Peter
    H. Kamin Revocable Trust dated February 2003	 	 		 
	Peter
    H. Kamin Childrens Trust dated March 1997	 	 		 
	Peter
    H. Kamin Family Foundation	 	 		 
	3K
    Limited Partnership	 	 		 
	Total

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]